NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/12/2023
Voltar para busca
Dado oficial do USPTO
VERISAVE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
VERISAVE
ST13
US500000090567728Classe
35, 36, 42, 45
Pedido
90567728
Registro
7243217
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
12/12/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 36, 42, 45
Data de depósito
09/03/2021
Data de registro
12/12/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/12/2023
Última transação
12/12/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
02/12/2021
Primeiro uso no comércio
27/01/2022
Código do desenho
4
Tipo de titular
03
Localização do titular
Kirkland, WA, US
Examinador
COLLIS, BRIAN J
Unidade examinadora
O20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Verity Solutions Group, Inc.
Representantes
Lynne E. Graybeal PERKINS COIE LLP
Classificação técnica
Classes Nice
Classe 35Classe 36Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Advisory and consulting services in the field of cost management of pharmaceuticals; business advisory and consulting services in the field of pharmaceutical benefit programs; business advisory and consulting services in the field of pharmacy and prescription medication benefits; business advisory and consulting services in the field of pharmaceutical benefits; advisory and consulting services in the field of pharmaceutical purchasing and purchasing optimization; Business and inventory management services provided to eligible organizations in the healthcare fields for controlling drug inventories; business and inventory management services provided to eligible pharmacies for controlling drug inventories; consulting services in the field of pharmaceutical cost management services and drug utilization review services
Classe 36
Financial advisory and consulting services in the fields of pharmacy and prescription medication benefits; financial advisory and consulting services in the field of pharmaceutical benefits; advisory and consulting services in the field of pharmaceutical benefit management services; advisory and consulting services in the field of pharmaceutical benefit management services of Federal 340B pharmacy programsdiscount prescription drug program
Classe 42
Software as a service (SaaS) services featuring software for purchasing pharmaceuticals; software as a service (SaaS) services featuring software for automated purchasing optimization; software as a service (SaaS) services featuring software for cost management in the field of purchasing pharmaceuticals; software as a service (SAAS) services featuring software that allows users to purchase pharmaceuticals for competitive prices; software as a service (SAAS) services featuring software that provides automated drug buying selections based on the best blended price in individual orders; software as a service (SAAS) services featuring software that provides automated purchase optimization for pharmaceutical drugs; software as a service (SAAS) services featuring software for obtaining information on pharmaceuticals; software as a service (SAAS) services for pharmaceutical inventory management
Classe 45
Advisory and consulting services in the field of pharmaceutical regulatory compliance
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
12/12/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/11/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/11/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
14/09/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
13/09/2023
EX1G
SOU EXTENSION 1 GRANTED
13/09/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
13/09/2023
IUAF
USE AMENDMENT FILED
05/09/2023
EXT1
SOU EXTENSION 1 FILED
05/09/2023
EEXT
SOU TEAS EXTENSION RECEIVED
05/09/2023
EISU
TEAS STATEMENT OF USE RECEIVED
05/09/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/03/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/01/2023
PUBO
PUBLISHED FOR OPPOSITION
10/01/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/12/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
28/11/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
28/11/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
28/11/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
28/11/2022
DOCK
ASSIGNED TO EXAMINER
22/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/10/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/10/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/10/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/06/2022
GNFR
FINAL REFUSAL E-MAILED
09/06/2022
CNFR
FINAL REFUSAL WRITTEN
09/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/04/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/04/2022
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
25/10/2021
GPRA
PRIORITY ACTION E-MAILED
25/10/2021
CPRA
PRIORITY ACTION WRITTEN
25/10/2021
DOCK
ASSIGNED TO EXAMINER
01/10/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/06/2021
NWAP
NEW APPLICATION ENTERED
12/03/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace VERISAVE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.